1-Naphthyl 3,5-dinitrobenzoate

CAS No. 93261-39-3

1-Naphthyl 3,5-dinitrobenzoate( JMC-4 )

Catalog No. M27473 CAS No. 93261-39-3

1-Naphthyl 3,5-dinitrobenzoate is an inhibitor of 5-LOX can be used in studies about inflammatory therapy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 132 Get Quote
10MG 228 Get Quote
25MG 497 Get Quote
50MG 714 Get Quote
100MG 981 Get Quote
500MG 1998 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    1-Naphthyl 3,5-dinitrobenzoate
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Naphthyl 3,5-dinitrobenzoate is an inhibitor of 5-LOX can be used in studies about inflammatory therapy.
  • Description
    1-Naphthyl 3,5-dinitrobenzoate is an inhibitor of 5-LOX can be used in studies about inflammatory therapy.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    JMC-4
  • Pathway
    Immunology/Inflammation
  • Target
    Lipoxygenase
  • Recptor
    nAChR1|nAChR2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    93261-39-3
  • Formula Weight
    338.27
  • Molecular Formula
    C17H10N2O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OC1=CC=CC=2C=CC=CC12)C=3C=C(C=C(C3)N(=O)=O)N(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jean-No?l Houchat, et al. Mode of Action of Sulfoxaflor on α-bungarotoxin-insensitive nAChR1 and nAChR2 Subtypes: Inhibitory Effect of Imidacloprid. Neurotoxicology. 2019 Sep;74:132-138.
molnova catalog
related products
  • Butibufen

    Butibufen (FF-106) is an orally active non-steroidal anti-inflammatory compound, a potential cyclooxygenase inhibitor with analgesic and antipyretic activity, and inhibits urea synthesis.Butibufen has been used in the study of rheumatic diseases.

  • BI-0115

    BI-0115 is a selective small molecule inhibitor of LOX-1 that blocks cellular uptake of oxLDL. It binding triggers receptor inhibition by formation of dimers of the homodimeric ligand binding domain.

  • CJ-13,610 hydrochlor...

    CJ-13,610 hydrochloride is an orally active nonredox-type inhibitor of 5-LOX and can be used in studies about the prevention of untoward pathophysiological effects of LTs.